Finance

ARK believes technology will boost the NPV of biopharmaceutical pipeline assets significantly during the next five to ten years.

Richard Branson’s rocket ride is about to become a reality.

Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech.

Background check data weighed the entire industry down.

They’ve just been deemed meme stocks and already are experiencing volatility.

Avis Budget Group has a lot to worry about.

The Chinese government continues its crackdown on private tutoring companies.

All of a sudden, the UAE wants out of the oil business.

A gene editing milestone sent the entire sector higher last month.

Branson’s flight will be a key moment in the company’s history.

Even with markets suffering, there were still some positives on Wall Street.

It seems this solar stock is back in Wall Street’s good graces.

The tech company turned a major outage into a positive event.

The narrative around Etsy has changed following two acquisitions in the last month.

COVID-19 concerns are driving the vaccine stocks higher.

Shares of the teen retailer fell along with the market, but there’s more to the story.

It’s a good news, bad news kind of a day for Tesla stockholders.

The stock price for The Bancorp is up 63% in 2021 and up almost 150% over the past 12 months.

Government regulation looms.

Teladoc is far more than a “COVID stock.” The market is underrating its long-term potential.